Softwr

Research · head to head

Greenphire vs LabVantage

Greenphire logo

Greenphire

Research

Clinical trial participant payments, reimbursement and travel, now part of Suvoda

From
On request
Rated
-
Full reviewWebsite
LabVantage logo

LabVantage

Research

Enterprise LIMS with integrated ELN and biobanking capability

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Greenphire the standalone greenphire.com site now redirects to Suvoda and the brands have been integrated, so buyers are contracting with a randomisation and supply vendor and should expect cross selling rather than an independent payments specialist.; LabVantage enterprise implementation weight, with configuration and validation measured in many months
  • They diverge on capability: Greenphire covers ClinCard, LabVantage covers Unified platform.
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which Greenphire and LabVantage actually diverge.

Attributes where Greenphire and LabVantage differ
AttributeGreenphireLabVantage
PlatformsWeb, iOS, AndroidWeb, Cloud, On-premise

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Research).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Greenphire

  • ClinCard
  • Direct to bank payment
  • Expense reimbursement
  • Travel and logistics
  • Site payments
  • Budgeting and benchmarking
  • Tax handling

Only in LabVantage

  • Unified platform
  • Biobanking
  • Instrument integration
  • Industry accelerators
  • Regulatory compliance
  • Web architecture

What people use each for

The jobs each tool is most often brought in to do.

Greenphire

  • A global Phase III trial paying stipends across many countries where participants cannot practically be reimbursed by sponsor accounts payablenot LabVantage
  • A decentralised or hybrid trial where participants travel long distances and the sponsor funds flights and accommodationnot LabVantage
  • A trial in a population where slow reimbursement drives dropout and same day payment materially helps retentionnot LabVantage
  • A sponsor that wants site payment milestones and participant payments handled by one vendor rather than twonot LabVantage

LabVantage

  • Laboratories wanting LIMS and ELN from one vendor rather than integrating twonot Greenphire
  • Biobanks managing specimen provenance, consent and long-term storagenot Greenphire
  • Pharmaceutical research organisations spanning discovery through QCnot Greenphire
  • Multi-site laboratory networks standardising on a single platformnot Greenphire

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Greenphire

  • The standalone greenphire.com site now redirects to Suvoda and the brands have been integrated, so buyers are contracting with a randomisation and supply vendor and should expect cross selling rather than an independent payments specialist.
  • Nothing is published on price, and the typical shape of a platform fee plus per participant and per transaction charges means the cost of a trial is not knowable until enrolment is known.
  • Payment method availability varies sharply by country, so a global protocol may end up with card payments in some regions and slow manual processes in others, which undermines the retention argument that justified the purchase.
  • Sites bear the administrative work of enrolling participants and triggering payments but are not the buyer, so adoption depends on the sponsor mandating it and site resistance is a real implementation risk.
  • Participant payments create tax reporting obligations that differ per jurisdiction, and the tooling helps but does not remove sponsor liability, so legal and finance review is required in every country the trial runs in.

LabVantage

  • Enterprise implementation weight, with configuration and validation measured in many months
  • Pricing is quote-based with no public entry point
  • The unified platform argument only pays off for laboratories that genuinely need all four capabilities; those needing only LIMS may find focused competitors better
  • Smaller installed base than LabWare, which matters in conservative laboratory procurement
  • Industry accelerators shorten implementation but do not remove the need for laboratory-specific configuration

Pricing, plan by plan

Greenphire

On request
  • Greenphire Patient Payments$undefined/year
    • Priced per study through a sales process
    • Typically a platform fee plus per participant and per transaction charges
    • Funding of the payment float is separate from the software fee

LabVantage

On request
  • LabVantage$undefined/year
    • LIMS
    • ELN
    • LES

Which should you pick?

Choose Greenphire if

  • You need clincard.
  • You work on Web, iOS, Android.
  • You also want direct to bank payment.
Greenphire review

Choose LabVantage if

  • You need unified platform.
  • You work on Web, Cloud, On-premise.
  • You also want biobanking.
LabVantage review

Questions people ask

Is Greenphire or LabVantage better?
Neither clearly leads. Greenphire starts at On request and LabVantage at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Greenphire or LabVantage?
Greenphire starts at On request and LabVantage at On request.
Does Greenphire or LabVantage run on more platforms?
Greenphire runs on Web, iOS, Android. LabVantage runs on Web, Cloud, On-premise.
What is Greenphire best used for?
Greenphire is most often used for a global phase iii trial paying stipends across many countries where participants cannot practically be reimbursed by sponsor accounts payable, a decentralised or hybrid trial where participants travel long distances and the sponsor funds flights and accommodation, a trial in a population where slow reimbursement drives dropout and same day payment materially helps retention, a sponsor that wants site payment milestones and participant payments handled by one vendor rather than two. Of those, a global phase iii trial paying stipends across many countries where participants cannot practically be reimbursed by sponsor accounts payable and a decentralised or hybrid trial where participants travel long distances and the sponsor funds flights and accommodation are not what LabVantage is typically brought in for.
What can Greenphire do that LabVantage cannot?
Greenphire covers ClinCard, Direct to bank payment, Expense reimbursement, Travel and logistics. LabVantage covers Unified platform, Biobanking, Instrument integration, Industry accelerators.

Answered from the vendors’ own pages

Greenphire: Is Greenphire still sold?

Yes, as Greenphire Patient Payments on the Suvoda platform. The independent website and social presence have been consolidated into Suvoda.

LabVantage: What does the unified platform actually mean?

LIMS, electronic laboratory notebook, laboratory execution and scientific data management as one product. Laboratories that would otherwise integrate and validate four vendors avoid that work.

Greenphire: What is ClinCard?

The reloadable debit card Greenphire issues to participants. Greenphire Patient Payments was formerly known as ClinCard.

LabVantage: Is biobanking really different?

Yes. Specimen provenance, consent tracking and decades-long storage are distinct from test result management, and the number of platforms handling them properly is small.

Greenphire: Does it publish pricing?

No. Pricing is per study and quoted through sales, and funding the payments themselves is separate from the software fee.

LabVantage: What does it cost?

Not published. Enterprise annual licensing plus implementation, quoted on scope.

Greenphire: Can it pay participants outside the United States?

Yes, in more than thirty currencies, but the available payment method depends on the country.

LabVantage: Do the industry accelerators shorten implementation?

They help by supplying pre-configured workflows for a vertical. They do not remove laboratory-specific configuration or, in regulated settings, validation.

LabVantage: How does it compare to LabWare?

LabWare has the larger installed base and deeper pharmaceutical QC dominance. LabVantage argues on the unified LIMS and ELN platform and on biobanking. Both are enterprise projects.

Share

Related pages

More on Greenphire

More on LabVantage

Keep looking

Other head to heads